A urinary test shows early potential for distinguishing which patients on prostate cancer active surveillance are at increased risk for cancer upgrading.
The US Food and Drug Administration has cleared Roche and partner Eli Lilly’s blood test to help identify signs of Alzheimer ...
The new test promises to be “minimally invasive” and can help doctors identify symptoms of Alzheimer’s disease earlier.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results